Press Releases Search News Category Company ReleasesCompany StatementsFinancial ReleasesProduct Releases Year None202320222021202020192018201720162015201420132012201120102009200820072006 Date Title PDF Version Oct 06, 2020 Alexion Highlights Promising Pipeline & Distinguished Rare Disease Capabilities at Virtual Investor Day Sep 25, 2020 ULTOMIRIS® (ravulizumab) Receives Approval in Japan for Atypical Hemolytic Uremic Syndrome (aHUS) in Adults and Children Sep 21, 2020 Alexion Receives CHMP Positive Opinion for New Advanced Formulation of ULTOMIRIS® (ravulizumab) with Significantly Reduced Infusion Time Sep 14, 2020 Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis Sep 14, 2020 Alexion to Discuss Key Pipeline Programs at Virtual Investor Day Sep 09, 2020 Alexion Announces Upcoming Data Presentations at MSVirtual2020, the 8th Joint ACTRIMS – ECTRIMS Meeting Sep 03, 2020 Alexion to Present at Upcoming Virtual Investor Conferences Aug 06, 2020 Alexion Announces Appointment of First Chief Diversity Officer Jul 30, 2020 Alexion Reports Second Quarter 2020 Results Jul 16, 2020 Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 41 - 50 of 626